Internal Server Error

List of Astrazeneca's Acquisitions

lockFilter this list
Astrazeneca has completed 23 acquisitions. Peak acquisition years were 2023 with 3, and 2024 and 2022 each with 2 acquisitions. Its acquisition activity spans 8 countries, focusing on United States (13), United Kingdom (3), and France (2). The acquisitions span 15 sectors, notably Oncology (11), Immunotherapy (7), and Diversified Pharmaceuticals (5). Over the last five years (2020–2025), the average number of acquisitions per year is 1.8. So far, 1 acquisition has been completed this calendar year. The most recent acquisition, completed in January 2026, was Modella, a Boston-based company founded in 2024 that develops artificial intelligence for biomedical imaging to enhance diagnostic workflows.

Here's the year on year acquisition history of Astrazeneca:

Year on year acquisition history of Astrazeneca2026202520242023202220212020Acquisitions Round Date (Yearly)01234
  • Number of Total Acquisitions
Year
# Acquisitions
2026
1
2025
1
2024
2
2023
3
2022
2
2021
1
2020
1
2015
2
2014
1
2013
2
2012
2
2009
1
2007
2
2006
1
2005
1

Recent acquisitions by Astrazeneca

Astrazeneca's most recent acquisition - Modella is a Developer of artificial intelligence for biomedical imaging, enhancing diagnostic workflows, founded in 2024 and located in Boston. Astrazeneca acquired it in January 2026 for a price of $*****.

Here is the list of all acquisitions by Astrazeneca sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Jan 13, 2026
arzh
mjkl
55
843
Mar 17, 2025
naqn
xatf
28
866
Mar 19, 2024
lrmf
riow
62
815
Mar 14, 2024
qzfj
pixx
65
464
Dec 26, 2023
v{bc
edbd
58
330

View the full list of acquisitions

Sign Up for Free

News related to Astrazeneca's acquisitions

lockFilter this list

Media has covered Astrazeneca for a total of 316 events in the last 1 year, 41 of them have been about acquisition activity.

View More Astrazeneca Recent News

FAQs about Acquisitions by Astrazeneca

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford